Bio
Mr. Le focuses on investment opportunities in biopharmaceuticals, medical devices, enterprise software and advanced materials. He has worked closely with the management teams and boards of Corus Pharma (acquired by Gilead Sciences), Halosource (LSE: HALO.L), Lumera (NasdaqNM:LMRA), and Performant (acquired by Mercury Interactive). He currently represents WRF Capital as a director of Accelerator, Acylin Therapeutics, ARZEDA, Groove Biopharma, Oncofactor and XORI, and is a board observer at Alder Biopharmaceuticals, Hyperion Therapeutics, Pathway Medical Technologies, Uptake Medical and VLST. Prior to joining WRF Capital, Mr. Le was the founder, president and chief executive officer of MiniMeals, Inc. and a consultant for Capital Management Consulting, Inc. Earlier, he was at Raymond James & Associates, Singer & Xenos Investment Management Company and Capital Management Group LLC, a private investment firm specializing in biomedical ventures. Mr. Le completed post-graduate studies at the Templeton College of Oxford University and earned a bachelor of arts cum laude in economics and government from Harvard University. He also serves on the executive boards of the Evergreen Venture Capital Association (EVCA), the Washington Biotechnology & Biomedical Association (WBBA), the Harvard Club of Seattle, and the Washington Global Health Technologies Competitiveness Fund.
Career
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
VinaCapital Investment Management Ltd - founderInvestment management firmVINACAPITAL INVESTMENT MANAGEMENT LTD Management Business District 1, Ho Chi Minh City From
VINACAPITAL INVESTMENT MANAGEMENT LTD Management Business Thành Phố HCM From
VINACAPITAL INVESTMENT MANAGEMENT LTD Management Business Saint Peter Port From
VINACAPITAL INVESTMENT MANAGEMENT LTD Management Business VG From
VINACAPITAL INVESTMENT MANAGEMENT LTD Management Business TP Hồ Chí Minh From
|
||
|
WRF CapitalEmail: [email protected] |